Synthesis and biological evaluation of new β-D-N4-hydroxycytidine analogs against SARS-CoV-2, influenza viruses and DENV-2
Bioorganic & Medicinal Chemistry Letters · 2023
DOI: 10.1016/j.bmcl.2023.129174 ↗Kurz gefasst
Fachartikel in der Zeitschrift Bioorganic & Medicinal Chemistry Letters, 2023. Verfasst von Yeon Jin An und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medicinal Biotechnology, College of Health Sciences, Dong-A University, Busan 49315, South Korea. Hauptthemen laut MEDLINE: Influenza A Virus, H1N1 Subtype, COVID-19. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 36 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).
Abstract (Originalsprache)
Drug repurposing approach was applied to find a potent antiviral agent against RNA viruses such as SARS-CoV-2, influenza viruses and dengue virus with a concise strategy of small change in parent molecular structure. For this purpose, β-D-N4-hydroxycytidine (NHC, 1) with a broad spectrum of antiviral activity was chosen as the parent molecule. Among the prepared NHC analogs (8a-g, and 9) from uridine, β-D-N4-O-isobutyrylcytidine (8a) showed potent activity against SARS-CoV-2 (EC50 3.50 μM), Flu A (H1N1) (EC50 5.80 μM), Flu A (H3N2) (EC50 7.30 μM), Flu B (EC50 3.40 μM) and DENV-2 (EC50 3.95 μM) in vitro. Furthermore, its potency against SARS-CoV-2 was >5-fold, 3.4-fold, and 3-fold compared to that of NHC (1), MK-4482 (2), and remdesivir (RDV) in vitro, respectively. Ultimately, compound 8a was expected to be a potent inhibitor toward RNA viruses as a viral mutagenic agent like MK-4482.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Medicinal Biotechnology, College of Health Sciences, Dong-A University, Busan 49315, South Korea.
- Infectious Diseases Therapeutic Research Center, Korea Research Institute of Chemical Technology (KRICT), Daejeon 34114, South Korea; Graduate School of New Drug Discovery and Development, Chungnam National University,…
- Infectious Diseases Therapeutic Research Center, Korea Research Institute of Chemical Technology (KRICT), Daejeon 34114, South Korea.
- Department of Medicinal Biotechnology, College of Health Sciences, Dong-A University, Busan 49315, South Korea; Department of Translational Biomedical Sciences, Graduate School of Dong-A University, Busan 49201, South K…
Zitieren
APA
An, Y. J., Choi, S. M., Choi, E. R., Nam, Y. E., Seo, E. W., Ahn, S. B., Jang, Y., Kim, M., & Cho, J. H. (2023). Synthesis and biological evaluation of new β-D-N4-hydroxycytidine analogs against SARS-CoV-2, influenza viruses and DENV-2. Bioorganic & Medicinal Chemistry Letters. https://doi.org/10.1016/j.bmcl.2023.129174
Vancouver
An YJ, Choi SM, Choi ER, Nam YE, Seo EW, Ahn SB, et al. Synthesis and biological evaluation of new β-D-N4-hydroxycytidine analogs against SARS-CoV-2, influenza viruses and DENV-2. Bioorganic & Medicinal Chemistry Letters. 2023. doi:10.1016/j.bmcl.2023.129174
BibTeX
@article{An2023,
author = {An, Yeon Jin and Choi, Se Myeong and Choi, Eun Rang and Nam, Ye Eun and Seo, Eun Woo and Ahn, Soo Bin and Jang, Yejin and Kim, Meehyein and Cho, Jong Hyun},
title = {Synthesis and biological evaluation of new β-D-N4-hydroxycytidine analogs against SARS-CoV-2, influenza viruses and DENV-2},
journal = {Bioorganic & Medicinal Chemistry Letters},
year = {2023},
doi = {10.1016/j.bmcl.2023.129174}
}
EUVIMED